Skip to main content
News

Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names | Xconomy

By August 13, 2012No Comments
NewImage

NewImage

The average American on the street has a Facebook account, an opinion about Facebook, heard about the Facebook initial public offering, and knows it collapsed. That same person doesn’t see how their life connects with biotech, probably can’t name a single biotech company, and certainly hasn’t heard of any members of the biotech IPO class of 2012.

But here’s something that might surprise both biotech insiders and the average guy or gal on the street. The biotech IPO class of 2012 has made money for investors, while tech’s most glamorous up-and-comers have been stumbling.

{iframe}http://www.xconomy.com/national/2012/08/13/biotech-ipos-are-beating-techs-big-names/?utm_source=rss&utm_medium=rss&utm_campaign=biotech-ipos-are-beating-techs-big-names&utm_source=Xconomy&utm_campaign=6f278d92d0-NEWSLETTER_ALL_STORIES&utm_medium=email{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.